APA (7th ed.) Citation

O, H., R, D. C. M., D, Z., DM, A., JJ, O., LC, C., . . . DP, P. (2023). Altered Arylamine N-acetyltransferase 1 and miR-1290 Levels in Childhood Acute Lymphoblastic Leukemia: A Pilot Study. In vivo (Athens, Greece), 37(3), 1129. https://doi.org/10.21873/invivo.13188

Chicago Style (17th ed.) Citation

O, Hernandez-Gonzalez, Del Carmen Milan-Segovia R, Zavala-Reyes D, Alvarado-Zamarripa DM, Ortiz-Zamudio JJ, Correa-Gonzalez LC, Vargas-Morales JM, Uresti-Rivera EE, and Portales-Perez DP. "Altered Arylamine N-acetyltransferase 1 and MiR-1290 Levels in Childhood Acute Lymphoblastic Leukemia: A Pilot Study." In Vivo (Athens, Greece) 37, no. 3 (2023): 1129. https://doi.org/10.21873/invivo.13188.

MLA (9th ed.) Citation

O, Hernandez-Gonzalez, et al. "Altered Arylamine N-acetyltransferase 1 and MiR-1290 Levels in Childhood Acute Lymphoblastic Leukemia: A Pilot Study." In Vivo (Athens, Greece), vol. 37, no. 3, 2023, p. 1129, https://doi.org/10.21873/invivo.13188.